Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-003874
Filing Date
2022-01-19
Accepted
2022-01-19 20:04:14
Documents
1
Period of Report
2022-01-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7477
  Complete submission text file 0001209191-22-003874.txt   8956
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 8585521100
QUIDEL CORP /DE/ (Issuer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O QUIDEL CORPORATION 12544 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
Bujarski Robert Joseph (Reporting) CIK: 0001333458 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-10961 | Film No.: 22540280